Healthcare and Venom Research
Healthcare and Venom Research is a research topic within Pharmacology. Science Explorer counts 29k research works in it since 1950. 6.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the therapeutic potential of bee venom and its constituent compounds, particularly melittin, in various medical applications. The research covers anti-cancer effects, pain relief, anti-inflammatory properties, apoptosis induction, and potential use in conditions such as rheumatoid arthritis and neurodegenerative diseases. Additionally, it investigates the use of bee venom in acupuncture and its immunomodulatory effects.
- Bee Venom
- Melittin
- Anti-cancer
- Pain Relief
- Anti-inflammatory
- Apoptosis Induction
- Rheumatoid Arthritis
- Neuroprotective Effects
- Acupuncture
- Immunomodulation
- Research works
- 29k fractional, since 1950
- In the world top 10%
- 2k per year above
- Top-10% rate
- 6.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -25% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Healthcare and Venom Research research?
By volume, China and South Korea publish the most (955 and 332 works in 2022–2025).
By volume, 2022–2025
- 1 China 955 works
- 2 South Korea 332 works
- 3 India 308 works
- 4 United States 301 works
- 5 Indonesia 261 works
- 6 Türkiye 160 works
- 7 Egypt 148 works
- 8 Brazil 139 works
- 9 Iran 118 works
- 10 Japan 100 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Healthcare and Venom Research research?
By volume in 2022–2025, Shaanxi University of Chinese Medicine publishes the most Healthcare and Venom Research research, followed by Kyung Hee University and Beijing University of Chinese Medicine.
By volume, 2022–2025
- 1 Shaanxi University of Chinese MedicineChina 33 works
- 2 Kyung Hee UniversitySouth Korea 30 works
- 3 Beijing University of Chinese MedicineChina 30 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 25 works
- 5 Dunsan Korean Medicine HospitalSouth Korea 23 works
- 6 Shanghai University of Traditional Chinese MedicineChina 21 works
- 7 Cairo UniversityEgypt 18 works
- 8 Chengdu University of Traditional Chinese MedicineChina 17 works
- 9 Jaseng Hospital of Korean MedicineSouth Korea 16 works
- 10 Nanjing University of Chinese MedicineChina 15 works
Who are the leading researchers in Healthcare and Venom Research?
The most-cited researchers publishing on Healthcare and Venom Research include Flavia Cicuttini.
- 1 Flavia Cicuttini Australia 3.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Healthcare and Venom Research research done?
The largest centres of Healthcare and Venom Research research in 2022–2025 are Beijing (China), Seoul (South Korea), Shanghai (China) and Daejeon (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Xianyang, Daejeon and Busan.
Largest cities, 2022–2025
Where it is the local speciality
- XianyangCN · 45.8 works55×
- DaejeonKR · 60.7 works9.0×
- BusanKR · 28.8 works8.7×
Location quotient: how much more of its research is in Healthcare and Venom Research than the world average.
Where is the best place to study Healthcare and Venom Research?
Among universities, judged by research, Chengdu University of Traditional Chinese Medicine, Kyung Hee University and Shanghai University of Traditional Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chengdu University of Traditional Chinese MedicineChina | 66.4 | 26.0% | 21.0× | 17 | -83.7% |
| 2 | Kyung Hee UniversitySouth Korea | 61.2 | 5.6% | 22.9× | 30 | -1.0% |
| 3 | Shanghai University of Traditional Chinese MedicineChina | 58.3 | 15.3% | 30.3× | 21 | -77.6% |
| 4 | Beijing University of Chinese MedicineChina | 57.9 | 10.9% | 47.4× | 30 | -72.6% |
| 5 | Nanjing University of Chinese MedicineChina | 57.8 | 19.6% | 16.6× | 15 | -68.3% |
| 6 | Zhejiang Chinese Medical UniversityChina | 54.8 | 18.6% | 14.5× | 13 | -81.4% |
| 7 | Zagazig UniversityEgypt | 54.7 | 6.7% | 8.4× | 12 | +169.2% |
| 8 | Guangzhou University of Chinese MedicineChina | 54.0 | 17.2% | 19.4× | 13 | -78.3% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 50.1 | 12.7% | 7.0× | 25 | -60.2% |
| 10 | Cairo UniversityEgypt | 49.3 | 4.1% | 6.3× | 18 | +150.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Healthcare and Venom Research research growing?
Output in 2018–2022 was 25% lower than in 2013–2017, peaking in 2013.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.